×




Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization case study is a Harvard Business School (HBR) case study written by Robert Chess, Ryan Kissick. The Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization (referred as “Stanford Medicine” from here on) case study provides evaluation & decision scenario in field of Technology & Operations. It also touches upon business topics such as - Value proposition, IT.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization Case Study


"Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization" examines how a complex medical organization evaluates new health information technology products to pilot, purchase, and utilize. Every year, hundreds of companies pitched their health IT solutions to Stanford Medicine and its associated entities: the Stanford University School of Medicine, Lucile Packard Children's Hospital Stanford, and Stanford Health Care. However, Stanford Medicine would only select a few of these IT products to purchase and implement. Highlighting a few specific health information technology companies and products, this case explores the organizational decision-making process at Stanford Medicine and the criteria used to evaluate new technologies.


Case Authors : Robert Chess, Ryan Kissick

Topic : Technology & Operations

Related Areas : IT




Calculating Net Present Value (NPV) at 6% for Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10024092) -10024092 - -
Year 1 3465947 -6558145 3465947 0.9434 3269761
Year 2 3971197 -2586948 7437144 0.89 3534351
Year 3 3962758 1375810 11399902 0.8396 3327208
Year 4 3222684 4598494 14622586 0.7921 2552668
TOTAL 14622586 12683988




The Net Present Value at 6% discount rate is 2659896

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Net Present Value
2. Internal Rate of Return
3. Payback Period
4. Profitability Index

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Stanford Medicine shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Stanford Medicine have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Technology & Operations Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Stanford Medicine often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Stanford Medicine needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10024092) -10024092 - -
Year 1 3465947 -6558145 3465947 0.8696 3013867
Year 2 3971197 -2586948 7437144 0.7561 3002795
Year 3 3962758 1375810 11399902 0.6575 2605578
Year 4 3222684 4598494 14622586 0.5718 1842580
TOTAL 10464820


The Net NPV after 4 years is 440728

(10464820 - 10024092 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10024092) -10024092 - -
Year 1 3465947 -6558145 3465947 0.8333 2888289
Year 2 3971197 -2586948 7437144 0.6944 2757776
Year 3 3962758 1375810 11399902 0.5787 2293263
Year 4 3222684 4598494 14622586 0.4823 1554149
TOTAL 9493477


The Net NPV after 4 years is -530615

At 20% discount rate the NPV is negative (9493477 - 10024092 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Stanford Medicine to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Stanford Medicine has a NPV value higher than Zero then finance managers at Stanford Medicine can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Stanford Medicine, then the stock price of the Stanford Medicine should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Stanford Medicine should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What can impact the cash flow of the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

Understanding of risks involved in the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization

References & Further Readings

Robert Chess, Ryan Kissick (2018), "Stanford Medicine: Health IT Purchasing Decisions in a Complex Medical Organization Harvard Business Review Case Study. Published by HBR Publications.


Petra Diamonds SWOT Analysis / TOWS Matrix

Basic Materials , Non-Metallic Mining


Sabina Gold&Silver SWOT Analysis / TOWS Matrix

Basic Materials , Gold & Silver


Syrah Resources SWOT Analysis / TOWS Matrix

Basic Materials , Gold & Silver


Kodensha SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


China Ocean Fishing SWOT Analysis / TOWS Matrix

Basic Materials , Misc. Fabricated Products


Ashoka Buildcon Ltd SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


Cellumed SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


CAR Inc SWOT Analysis / TOWS Matrix

Services , Rental & Leasing